FDA halts food manufacturing facility inspections to slow coronavirus spread

| | March 25, 2020
fda signage
Credit: FDA
This article or excerpt is included in the GLP’s daily curated selection of ideologically diverse news, opinion and analysis of biotechnology innovation.

In light of the COVID-19 pandemic and efforts to “flatten the curve,” the Food and Drug Administration (FDA) is halting all routine surveillance inspections of facilities that manufacture food and other FDA-regulated products, the federal agency announced on March 18.

This change, which comes a week after the FDA announced the suspension of most foreign inspections, affects domestic inspections traditionally conducted every few years based on risk analysis.

In lieu of these inspections, the FDA is considering other ways to conduct inspectional work while maintaining public safety and protecting both factory and FDA staff. “This can include, among other things, evaluating records in lieu of conducting an onsite inspection on an interim basis when travel is not permissible, when appropriate,” FDA commissioner Stephen Hahn said in a statement.

Related article:  Video: Why we should ignore most reported COVID-19 statistics

The U.S. Department of Agriculture (USDA), which mainly oversees meat, poultry, and egg products, issued a statement on March 17 saying it would continue normal inspection services while working to ensure the safety of employees …. But approximately 77 percent of the U.S. food supply — including dairy, seafood, produce, processed and packaged foods, bottled water, and shelled eggs — is regulated by the FDA.

Read the original post

Share via
News on human & agricultural genetics and biotechnology delivered to your inbox.
Optional. Mail on special occasions.
Send this to a friend